{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:29:48Z","timestamp":1791660588560,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00520-025-09826-7","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T10:40:54Z","timestamp":1754476854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The impact of palliative care consults on medicines optimisation for patients with cancer referred to hospice care at the end of life: a retrospective cohort study"],"prefix":"10.1007","volume":"33","author":[{"given":"Tahani","family":"Alwidyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Shamieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Alrjoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghadeer","family":"Alarjeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"9826_CR1","doi-asserted-by":"publisher","first-page":"j878","DOI":"10.1136\/bmj.j878","volume":"356","author":"SA Murray","year":"2017","unstructured":"Murray SA, Kendall M, Mitchell G, Moine S, Ambl\u00e0s-Novellas J, Boyd K (2017) Palliative care from diagnosis to death. BMJ 356:j878","journal-title":"BMJ"},{"key":"9826_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/clpt.2008.211","volume":"85","author":"H Holmes","year":"2009","unstructured":"Holmes H (2009) Rational prescribing for patients with a reduced life expectancy. Clin Pharmacol Ther 85:103\u2013107","journal-title":"Clin Pharmacol Ther"},{"key":"9826_CR3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.4143\/crt.2013.45.3.220","volume":"45","author":"HR Lee","year":"2013","unstructured":"Lee HR, Yi SY (2013) Evaluation of prescribing medications for terminal cancer patients near death: essential or futile. Cancer Research and Treatment: Official Journal of Korean Cancer Association 45:220\u2013225","journal-title":"Cancer Research and Treatment: Official Journal of Korean Cancer Association"},{"key":"9826_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE (2017) What is polypharmacy? A systematic review of definitions. BMC Geriatr 17:1\u201310","journal-title":"BMC Geriatr"},{"key":"9826_CR5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.7861\/clinmedicine.16-5-465","volume":"16","author":"RA Payne","year":"2016","unstructured":"Payne RA (2016) The epidemiology of polypharmacy. Clin Med 16:465\u2013469","journal-title":"Clin Med"},{"key":"9826_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/TCRM.S214187","volume":"16","author":"N Taghy","year":"2020","unstructured":"Taghy N, Cambon L, Cohen J-M, Dussart C (2020) Failure to reach a consensus in polypharmacy definition: an obstacle to measuring risks and impacts\u2014results of a literature review. Ther Clin Risk Manag 16:57\u201373","journal-title":"Ther Clin Risk Manag"},{"key":"9826_CR7","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/bcp.12284","volume":"77","author":"CM Hughes","year":"2014","unstructured":"Hughes CM, Cooper JA, Ryan C (2014) Going beyond the numbers\u2013a call to redefine polypharmacy. Br J Clin Pharmacol 77:915\u2013916","journal-title":"Br J Clin Pharmacol"},{"key":"9826_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40780-019-0143-5","volume":"5","author":"M Uchida","year":"2019","unstructured":"Uchida M, Suzuki S, Sugawara H, Suga Y, Kokubun H, Uesawa Y et al (2019) A nationwide survey of hospital pharmacist interventions to improve polypharmacy for patients with cancer in palliative care in Japan. Journal of Pharmaceutical Health Care and Sciences 5:1\u201313","journal-title":"Journal of Pharmaceutical Health Care and Sciences"},{"key":"9826_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/02692163231209024","volume":"38","author":"T Alwidyan","year":"2023","unstructured":"Alwidyan T, McCorry NK, Black C, Coulter R, Forbes J, Parsons C (2023) Prescribing and deprescribing in older people with life-limiting illnesses receiving hospice care at the end of life: a longitudinal, retrospective cohort study. Palliat Med 38:121\u2013130","journal-title":"Palliat Med"},{"key":"9826_CR10","unstructured":"Organization WH (2019) Medication safety in polypharmacy: technical report. https:\/\/iris.who.int\/bitstream\/handle\/10665\/325454\/WHO-UHC-SDS-2019.11-eng.pdf?sequence=1. Accessed 23 Jan 2025"},{"key":"9826_CR11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/ageing\/afaa159","volume":"50","author":"D Curtin","year":"2021","unstructured":"Curtin D, Gallagher P, O\u2019Mahony D (2021) Deprescribing in older people approaching end-of-life: development and validation of STOPPFrail version 2. Age Ageing 50:465\u2013471","journal-title":"Age Ageing"},{"key":"9826_CR12","first-page":"71","volume":"23","author":"J Lindsay","year":"2015","unstructured":"Lindsay J, Dooley M, Martin J, Fay M, Kearney A, Khatun M et al (2015) The development and evaluation of an oncological palliative care deprescribing guideline: the \u2018OncPal deprescribing guideline.\u2019 Support Care Cancer 23:71\u201378","journal-title":"Support Care Cancer"},{"key":"9826_CR13","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s11096-018-0673-1","volume":"40","author":"S Scott","year":"2018","unstructured":"Scott S, Clark A, Farrow C, May H, Patel M, Twigg MJ et al (2018) Deprescribing admission medication at a UK teaching hospital; a report on quantity and nature of activity. Int J Clin Pharm 40:991\u2013996","journal-title":"Int J Clin Pharm"},{"key":"9826_CR14","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/bcp.13874","volume":"85","author":"K Paque","year":"2019","unstructured":"Paque K, De Schreye R, Elseviers M, Vander Stichele R, Pardon K, Dilles T et al (2019) Discontinuation of medications at the end of life: a population study in Belgium, based on linked administrative databases. Br J Clin Pharmacol 85:827\u2013837","journal-title":"Br J Clin Pharmacol"},{"key":"9826_CR15","first-page":"4107","volume":"28","author":"H Marin","year":"2020","unstructured":"Marin H, Mayo P, Thai V, Dersch-Mills D, Ling S, Folkman F et al (2020) The impact of palliative care consults on deprescribing in palliative cancer patients. Support Care Cancer 28:4107\u20134113","journal-title":"Support Care Cancer"},{"key":"9826_CR16","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1089\/jpm.2018.0431","volume":"21","author":"BR Ferrell","year":"2018","unstructured":"Ferrell BR, Twaddle ML, Melnick A, Meier DE (2018) National consensus project clinical practice guidelines for quality palliative care guidelines, 4th edition. J Palliat Med 21:1684\u20139","journal-title":"J Palliat Med"},{"key":"9826_CR17","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1056\/NEJMsb1305469","volume":"369","author":"RB Parikh","year":"2013","unstructured":"Parikh RB, Kirch RA, Smith TJ, Temel JS (2013) Early specialty palliative care\u2013translating data in oncology into practice. N Engl J Med 369:2347\u20132351","journal-title":"N Engl J Med"},{"key":"9826_CR18","first-page":"1407","volume":"15","author":"RP Riechelmann","year":"2007","unstructured":"Riechelmann RP, Krzyzanowska MK, O\u2019Carroll A, Zimmermann C (2007) Symptom and medication profiles among cancer patients attending a palliative care clinic. Support Care Cancer 15:1407\u20131412","journal-title":"Support Care Cancer"},{"key":"9826_CR19","first-page":"427","volume":"23","author":"D Hui","year":"2015","unstructured":"Hui D, Li Z, Chisholm GB, Didwaniya N, Bruera E (2015) Changes in medication profile among patients with advanced cancer admitted to an acute palliative care unit. Support Care Cancer 23:427\u2013432","journal-title":"Support Care Cancer"},{"key":"9826_CR20","unstructured":"Medicines NICE, UK PC (2015) Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes. National Institute for Health and Care Excellence (NICE), Manchester"},{"issue":"5","key":"9826_CR21","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","volume":"175","author":"I Scott","year":"2015","unstructured":"Scott I, Hilmer S, Reeve E, Potter K, Le Couteur D, Rigby D et al (2015) Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med 175(5):827\u2013834. https:\/\/doi.org\/10.1001\/jamainternmed.2015.0324","journal-title":"JAMA Intern Med"},{"key":"9826_CR22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/ajag.12355","volume":"36","author":"JB Broad","year":"2017","unstructured":"Broad JB, Dunstan K, Claridge A, Harris R (2017) Am i too old for this, doctor? Using population life expectancy to guide clinical decision-making. Australas J Ageing 36:60\u201364","journal-title":"Australas J Ageing"},{"key":"9826_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jpainsymman.2013.02.021","volume":"47","author":"D Hui","year":"2014","unstructured":"Hui D, Nooruddin Z, Didwaniya N, Dev R, De La Cruz M, Kim SH et al (2014) Concepts and definitions for \u201cactively dying\u201d,\u201cend of life\u201d,\u201cterminally ill\u201d,\u201cterminal care\u201d, and \u201ctransition of care\u201d: a systematic review. J Pain Symptom Manage 47:77\u201389","journal-title":"J Pain Symptom Manage"},{"key":"9826_CR24","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jpainsymman.2008.08.003","volume":"37","author":"F Lau","year":"2009","unstructured":"Lau F, Maida V, Downing M, Lesperance M, Karlson N, Kuziemsky C (2009) Use of the palliative performance scale (PPS) for end-of-life prognostication in a palliative medicine consultation service. J Pain Symptom Manage 37:965\u2013972","journal-title":"J Pain Symptom Manage"},{"key":"9826_CR25","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1089\/jpm.2016.0108","volume":"19","author":"K Sato","year":"2016","unstructured":"Sato K, Miyashita M, Morita T, Tsuneto S, Shima Y (2016) End-of-life medical treatments in the last two weeks of life in palliative care units in Japan, 2005\u20132006: a nationwide retrospective cohort survey. J Palliat Med 19:1188\u20131196","journal-title":"J Palliat Med"},{"key":"9826_CR26","unstructured":"Partnership GMHaSC (2019) Palliative care pain and symptom control guidelines for adults. https:\/\/www.england.nhs.uk\/north-west\/wp-content\/uploads\/sites\/48\/2020\/01\/Palliative-Care-Pain-and-Symptom-Control-Guidelines.pdf. Accessed 19 Sept 2022"},{"key":"9826_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1179\/174329111X576698","volume":"19","author":"AR Maddison","year":"2011","unstructured":"Maddison AR, Fisher J, Johnston G (2011) Preventive medication use among persons with limited life expectancy. Prog Palliat Care 19:15\u201321","journal-title":"Prog Palliat Care"},{"key":"9826_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1136\/ejhpharm-2021-003143","volume":"31","author":"LN van Merendonk","year":"2024","unstructured":"van Merendonk LN, Peters BJ, M\u00f6hlmann JE, Hunting CB, Kastelijn EA, van den Broek MP (2024) The potential for deprescribing in a palliative oncology patient population: a cross-sectional study. Eur J Hosp Pharm 31:10\u201315","journal-title":"Eur J Hosp Pharm"},{"key":"9826_CR29","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.jpainsymman.2016.12.350","volume":"53","author":"A Poudel","year":"2017","unstructured":"Poudel A, Yates P, Rowett D, Nissen LM (2017) Use of preventive medication in patients with limited life expectancy: a systematic review. J Pain Symptom Manage 53:1097\u20131110","journal-title":"J Pain Symptom Manage"},{"key":"9826_CR30","doi-asserted-by":"publisher","first-page":"204209862110523","DOI":"10.1177\/20420986211052343","volume":"12","author":"S Shrestha","year":"2021","unstructured":"Shrestha S, Poudel A, Cardona M, Steadman KJ, Nissen LM (2021) Impact of deprescribing dual-purpose medications on patient-related outcomes for older adults near end-of-life: a systematic review and meta-analysis. Ther Adv Drug Saf 12:20420986211052344","journal-title":"Ther Adv Drug Saf"},{"key":"9826_CR31","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1089\/jpm.2023.0520","volume":"27","author":"S Masumoto","year":"2024","unstructured":"Masumoto S, Hosoi T, Nakamura T, Hamano J (2024) Polypharmacy and potentially inappropriate medications in patients with advanced cancer: prevalence and associated factors at the end of life. J Palliat Med 27:749\u2013755","journal-title":"J Palliat Med"},{"key":"9826_CR32","first-page":"100050","volume":"3","author":"CA Cadogan","year":"2021","unstructured":"Cadogan CA, Murphy M, Boland M, Bennett K, McLean S, Hughes C (2021) Prescribing practices, patterns, and potential harms in patients receiving palliative care: a systematic scoping review. Explor Res Clin Soc Pharm 3:100050","journal-title":"Explor Res Clin Soc Pharm"},{"key":"9826_CR33","doi-asserted-by":"publisher","DOI":"10.21037\/apm-22-623","volume":"11","author":"H Ohinata","year":"2022","unstructured":"Ohinata H, Aoyama M, Miyashita M (2022) Complexity in the context of palliative care: a systematic review. Ann Palliat Med 11:3231246\u20133233246","journal-title":"Ann Palliat Med"},{"key":"9826_CR34","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/j.1532-5415.2007.01124.x","volume":"55","author":"DC Currow","year":"2007","unstructured":"Currow DC, Stevenson JP, Abernethy AP, Plummer J, Shelby-James TM (2007) Prescribing in palliative care as death approaches. J Am Geriatr Soc 55:590\u2013595","journal-title":"J Am Geriatr Soc"},{"key":"9826_CR35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.amjopharm.2009.02.001","volume":"7","author":"EM Suhrie","year":"2009","unstructured":"Suhrie EM, Hanlon JT, Jaffe EJ, Sevick MA, Ruby CM, Aspinall SL (2009) Impact of a geriatric nursing home palliative care service on unnecessary medication prescribing. Am J Geriatr Pharmacother 7:20\u201325","journal-title":"Am J Geriatr Pharmacother"},{"key":"9826_CR36","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1177\/0269216315573687","volume":"29","author":"D Domingues","year":"2015","unstructured":"Domingues D, Carneiro R, Costa I, Monteiro C, Shvetz Y, Barbosa AC et al (2015) Therapeutic futility in cancer patients at the time of palliative care transition: an analysis with a modified version of the Medication Appropriateness Index. Palliat Med 29:643\u2013651","journal-title":"Palliat Med"},{"key":"9826_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00990","volume":"8","author":"HG Van der Meer","year":"2018","unstructured":"Van der Meer HG, Taxis K, Pont LG (2018) Changes in prescribing symptomatic and preventive medications in the last year of life in older nursing home residents. Front Pharmacol 8:990","journal-title":"Front Pharmacol"},{"key":"9826_CR38","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/1049909118794926","volume":"36","author":"L Pasina","year":"2019","unstructured":"Pasina L, Recchia A, Agosti P, Nobili A, Rizzi B (2019) Prevalence of preventive and symptomatic drug treatments in hospice care: an Italian observational study. Am J Hosp Palliat Med 36:216\u2013221","journal-title":"Am J Hosp Palliat Med"},{"issue":"545\u201351","key":"9826_CR39","volume":"25","author":"E Brunetti","year":"2024","unstructured":"Brunetti E, Presta R, Okoye C, Filippini C, Raspo S, Bruno G et al (2024) Predictors and Outcomes of Oral Anticoagulant Deprescribing in Geriatric Inpatients With Atrial Fibrillation: A Retrospective Multicenter Cohort Study. J Am Med Dir Assoc 25(545\u201351):e4","journal-title":"J Am Med Dir Assoc"},{"key":"9826_CR40","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1111\/jgs.16777","volume":"68","author":"DS Mack","year":"2020","unstructured":"Mack DS, Baek J, Tjia J, Lapane KL (2020) Statin discontinuation and life-limiting illness in non-skilled stay nursing homes at admission. J Am Geriatr Soc 68:2787\u20132796","journal-title":"J Am Geriatr Soc"},{"key":"9826_CR41","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1111\/jgs.16727","volume":"68","author":"CT Thorpe","year":"2020","unstructured":"Thorpe CT, Sileanu FE, Mor MK, Zhao X, Aspinall S, Ersek M et al (2020) Discontinuation of statins in veterans admitted to nursing homes near the end of life. J Am Geriatr Soc 68:2609\u20132619","journal-title":"J Am Geriatr Soc"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09826-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09826-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09826-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T03:02:11Z","timestamp":1758164531000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09826-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["9826"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09826-7","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All authors had complete access to the study data that support the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data access statement"}}],"article-number":"761"}}